Could Viking Therapeutics Next: Will It Challenge Lilly?
The race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A straightforward take on whether SP 500 or balanced funds fit better for retirement, covering growth potential, risk, and suitability.
25,481 articlesThe race to own the GLP-1 weight loss market has a new challenger in Viking Therapeutics. This article breaks down wh...
A new industry focus centers on converting existing leads. Real estate teams report faster traction by prioritizing f...
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
When a CEO discloses a large stock sale, markets react. This guide breaks down what sells $2.4 million international ...
Alphabet’s billion flex is more than just cash. It’s a strategic playbook that powers buybacks, AI investments, and l...
Private equity takes the helm at Pizza Hut in a $2.7 billion split deal, redefining a 1950s-era brand for the modern ...
Lyft’s leadership introduces a multi-sensor safety standard for autonomous rides, positioning safety at the center as...
As Salesforce unveils a strategic acquisition, investors are asking whether this move can truly beat the current SaaS...
A London concert schedule kept Harry Styles away from Taylor Swift’s high-profile wedding. This clash isn’t just abou...
Quantum computing stocks have sizzled, but reality bites. This article breaks down why this quantum computing stock m...
Netflix revealed it used AI to speed production on a documentary, delivering 17 minutes of AI-enhanced footage at hal...
Unlock the signals behind American Water Works earnings calls. Learn how to read the transcript, spot growth drivers,...